Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Lignende værker

• Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial
  af: Kempen, John H., et al.
  Udgivet: (2011)
• Cost-Effectiveness of Fluocinolone Acetonide Implant Versus Systemic Therapy for Non-infectious Intermediate, Posterior and Panuveitis
  af: Sugar, Elizabeth A., et al.
  Udgivet: (2014)
• Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  af: Holbrook, Janet T., et al.
  Udgivet: (2015)
• Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis
  af: Kempen, John H., et al.
  Udgivet: (2017)
• Factors Predicting Visual Acuity Outcome in Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  af: Kempen, John H., et al.
  Udgivet: (2015)